FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063397 [Registered on: 01/03/2024] Trial Registered Prospectively
Last Modified On: 28/02/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) [Tratment]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate clinical efficacy of ayurvedic package in children suffering from cerebral palsy 
Scientific Title of Study   To Evaluate Clinical Efficacy of Ayurvedic Package in Children Suffering from Cerebral Palsy 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Deepti Yadav 
Designation  Dch (Ay) 
Affiliation  Institute of Medical Sciences 
Address  Department of kaumarbhritya balroga Faculty of Ayurveda Institute of Medical sciences Banaras hindu university Varanasi Uttarpradesh
OPD No. - 25, sir sunder lal hospital, IMS, BHU
Varanasi
UTTAR PRADESH
221005
India 
Phone  9569998982  
Fax    
Email  y.deepti7894@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P S Upadhyay 
Designation  Assosciate professor 
Affiliation  Institute of Medical Sciences 
Address  Department of kaumarbhritya balroga Faculty of Ayurveda Institute of Medical sciences Banaras hindu university Varanasi Uttarpradesh
OPD No. - 25, sir sunder lal hospital, IMS, BHU
Varanasi
UTTAR PRADESH
221005
India 
Phone  7355422083  
Fax    
Email  psupadhyay08@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr P S Upadhyay 
Designation  Assosciate professor 
Affiliation  Institute of Medical Sciences 
Address  Department of kaumarbhritya balroga Faculty of Ayurveda Institute of Medical sciences Banaras hindu university Varanasi Uttarpradesh
OPD No. - 25, sir sunder lal hospital, IMS, BHU

UTTAR PRADESH
221005
India 
Phone  7355422083  
Fax    
Email  psupadhyay08@gmail.com  
 
Source of Monetary or Material Support  
Kaumarbhritya / Balroga, OPD No. 25, Indian medicine wing, Sir sunderlal hospital, IMS, BHU, Varanasi 
 
Primary Sponsor  
Name  Banaras HIndu University 
Address  Indian medicine wing, Sir sunderlal hospital, IMS, BHU, Varanasi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr P S Upadhyay  Sir Sunderlal Hospital, IMS, BHU  OPD No. - 25 (Bal Roga OPD), Kashyap Ward, Indian Medicine Wing
Varanasi
UTTAR PRADESH 
7355422083

psupadhyay08@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee, Institute of Medical Sciences, Banaras Hindu University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G809||Cerebral palsy, unspecified. Ayurveda Condition: PAKSHAGHATA/PAKSHAVADHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-abhyanga (Procedure Reference: Charak samhita, Procedure details: 15 minute/day)
(1) Medicine Name: Ksheerbala oil, Reference: Sahasrayoga, Route: Topical, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 21 Days
2Comparator ArmProcedure-abhyanga (Procedure Reference: charak samhita, Procedure details: 15 minute/ day)
(1) Medicine Name: Mahanarayan oil, Reference: Bhaishajya ratnavali, Route: Topical, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 21 Days
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Irrespective to sex.
Age between 1 to 10 years, suffering from any types of CP due to different etiology..
Whom parents have given consent for the participation of their kids in the proposed clinical trial.
 
 
ExclusionCriteria 
Details  Any CP child suffering any associated life- threatening diseases, malignancy, congenital heart disease, HIV, diabetes, congenital genetic disorder etc.
Patient/parent, has quit denied participating between the clinical during study.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
CBC LFT RFT CT brain MRI Brain Urine R M Stool R M EEG
 
Monthly follow up for 6 months
 
 
Secondary Outcome  
Outcome  TimePoints 
Anthropometry, milestones, muscle power, muscle tone, Deep tendon reflexes, Cortical thumb, Scissoring, drooling of saliva  monthly follow up for 6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Cerebral palsy is defined as a nonprogressive neuromotor disorder of cerebral origin. It includes heterogeneous clinical states of variable etiology and severity ranging from minor incapacitation to total handicap. Cerebral palsy (CP) is the leading cause of childhood disability affecting function and development.

Motor disorders of CP are often accompanied by disturbances of sensation, perception, cognition, communication and behavior. Most of the cases have multiple neurological deficits and variable mental handicap. It is difficult to estimate the precise magnitude of the problem since mild cases are likely to be missed. 

Approximately 1-2 per 100 live births is a reasonable estimate of the incidence. 

The global prevalence of CP is 2:1000 of the many types and subtypes of CP, none has any known “cure.” Ayurveda has a separate branch of clinical specialization concerning child healthcare known as Kaumārabhṛtya. There is no one to one correlation available in Ayurvedic classics with CP, but there are many conditions and some causative factors linked to etiopathology for such type of disease condition described in many chapters in different texts.

 


 
Close